Anthera Pharmaceuticals Inc ANTH Stock Analysis
- PINK
- Stock
- Market closed · opens Monday 9:30 AM ET
$0.00 unchanged at close Oct 14
Last close · Previous close $0.00
- Market cap
- At the Oct 14 close
- P/E ratio
- On last 12 months’ EPS
- Diluted EPS
- Last 12 months
- Dividend yield
- Last 12 months
Price chart
$0.00unchangedWed, Oct 14 session
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$0.00Oct 13
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Valuation
Financials
Dividends
About Anthera Pharmaceuticals Inc
Anthera Pharmaceuticals, Inc. (Anthera) is a development-stage, biopharmaceutical Company focused on developing and commercializing products to treat diseases associated with inflammation. As of December 31, 2011, the Company had one Phase-II clinical program, blisibimod. Two of its product candidates, varespladib and varespladib sodium, are designed to inhibit an enzyme target known as secretory phospholipase A2 (sPLA2). sPLA2 have been implicated in a range of acute inflammatory conditions, including acute coronary syndrome and acute chest syndrome associated with sickle cell disease, as well as in chronic diseases, including stable coronary artery disease (CAD). In addition, blisibimod targets B-lymphocyte stimulator (BLyS), also known as B-cell Activating Factor (BAFF), which has been associated with a range of B-cell mediated autoimmune diseases.
- Sector
- Industry
- Headquarters
- Exchange
- PINK
- Asset type
- Common stock
- Price history since
ANTH news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
ANTH stock FAQ
What is ANTH stock’s price today?
Anthera Pharmaceuticals (ANTH) traded at $0.00 at the close on , unchanged from the previous close of $0.00.
What exchange does ANTH trade on?
Anthera Pharmaceuticals trades on the PINK under the ticker symbol ANTH. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.